ad image

R&D

1 / 4
The White House’s War on the NIH and the Disasters Ahead
NIH

The White House’s War on the NIH and the Disasters Ahead

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-25-NI-05Mar 24, 2025
Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics

Magnetogenetics and the Future of Remote Biological Control

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-25-NI-04Mar 17, 2025
Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models
Collaboration

Three Decades of Collaboration: Evolution from Basic Partnerships to Complex Open-Innovation Models

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-25-30-14Mar 03, 2025
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
NIH Funding

NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk

David Alvaro, Ph.D.

Pharma's Almanac

PAO-02-25-NI-03Feb 10, 2025
Protein Science and the Future of Biotherapeutics
Bbiotherapeutics

Protein Science and the Future of Biotherapeutics

Mathias Uhlén, Ph.D.

NorthX Biologics

PAO-01-25-CL-07Jan 22, 2025
Bio-Techne Corporation
Protein Portfolio

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Corporation

PR-01-25-NI-05Jan 10, 2025
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Synthetic Biology

Queensland University of Technology's Cutting-Edge Synthetic Biology Lab

Queensland University of Technology (QUT)

PAO-11-24-RTM-06Nov 15, 2024
Plan Ahead: Mastering Your AI Budget for 2025 Success
AI

Plan Ahead: Mastering Your AI Budget for 2025 Success

Stephen Tharp

Dotmatics

PAO-10-24-CL-06Oct 07, 2024
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Biosimilars

Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars

Hugo Sotelo; Marcelo Criscuolo

Biosidus

PAO-07-24-CL-06Jul 16, 2024
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Biosimilars

Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets

Hugo Sotelo; Marcelo Criscuolo

Biosidus

PAO-07-24-CL-07Jul 16, 2024
Navigating the Global Regulatory Landscape for Biosimilars
Biosimilars

Navigating the Global Regulatory Landscape for Biosimilars

Veronica Grimoldi

Biosidus

PAO-07-24-CL-09Jul 16, 2024
Transforming the Management of Chronic Diseases with Biosimilars
Chronic Diseases

Transforming the Management of Chronic Diseases with Biosimilars

Hugo Sotelo; Jorge Catella

Biosidus

PAO-07-24-CL-10Jul 16, 2024
Revolutionizing Biologics (and Biology) through a Focus on Women
Women's Health

Revolutionizing Biologics (and Biology) through a Focus on Women

Chia Chia Sun; Gardiner Smith

Fab Biopharma

PAO-07-24-CL-03Jul 09, 2024
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

PAO-09-23-CL-02Sep 29, 2023
Who is Using FAIR Data in Life Sciences R&D Today?
Data Management

Who is Using FAIR Data in Life Sciences R&D Today?

Christian Olsen

Dotmatics

PAO-09-23-CL-05Sep 11, 2023
Integrating Digital Solutions to Streamline Biopharma Operations
R&D

Integrating Digital Solutions to Streamline Biopharma Operations

Christian Olsen

Dotmatics

PAO-07-23-CL-06Jul 17, 2023
Biologics Outsourcing: Decision Drivers and Key Considerations
Biomanufacturing

Biologics Outsourcing: Decision Drivers and Key Considerations

Scorpius BioManufacturing

PAO-04-23-CL-01Apr 18, 2023
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

Chris Berger; Kilian Witzel

Avid Bioservices

PAO-02-23-CL-03Mar 14, 2023
Dotmatics
Prism Integration

Dotmatics Scientific R&D Platform Introduces Built-in GraphPad Prism Integrations

Dotmatics

PR-M02-23-01Feb 08, 2023
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
Gene Tools

Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos

David Alvaro, Ph.D.; Jon Moulton, Ph.D.

Pharma's Almanac

PAO-01-23-CL-05Feb 01, 2023
1 / 4